These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 39267713)

  • 21. Estimation of colorectal adenoma recurrence with dependent censoring.
    Hsu CH; Long Q; Alberts DS
    BMC Med Res Methodol; 2009 Sep; 9():66. PubMed ID: 19788750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A simple hybrid variance estimator for the Kaplan-Meier survival function.
    Borkowf CB
    Stat Med; 2005 Mar; 24(6):827-51. PubMed ID: 15558837
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A partially parametric estimator of survival in the presence of randomly censored data.
    Klein JP; Lee SC; Moeschberger ML
    Biometrics; 1990 Sep; 46(3):795-811. PubMed ID: 2242415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simultaneous marginal survival estimators when doubly censored data is present.
    Julià O; Gómez G
    Lifetime Data Anal; 2011 Jul; 17(3):347-72. PubMed ID: 20886370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A regression-based method for estimating mean treatment cost in the presence of right-censoring.
    Carides GW; Heyse JF; Iglewicz B
    Biostatistics; 2000 Sep; 1(3):299-313. PubMed ID: 12933511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonparametric estimators of survival function under the mixed case interval-censored model with left truncation.
    Shen PS
    Lifetime Data Anal; 2020 Jul; 26(3):624-637. PubMed ID: 31930441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simple parametric survival analysis with anonymized register data: A cohort study with truncated and interval censored event and censoring times.
    Støvring H; Kristiansen IS
    BMC Res Notes; 2011 Aug; 4():308. PubMed ID: 21867515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved confidence intervals for a difference of two cause-specific cumulative incidence functions estimated in the presence of competing risks and random censoring.
    Scosyrev E
    Biom J; 2020 Oct; 62(6):1394-1407. PubMed ID: 32227361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Receiver operating characteristic curve estimation for time to event with semicompeting risks and interval censoring.
    Jacqmin-Gadda H; Blanche P; Chary E; Touraine C; Dartigues JF
    Stat Methods Med Res; 2016 Dec; 25(6):2750-2766. PubMed ID: 24803510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regression analysis of multivariate interval-censored failure time data with informative censoring.
    Yu M; Feng Y; Duan R; Sun J
    Stat Methods Med Res; 2022 Mar; 31(3):391-403. PubMed ID: 34878352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A robust weighted Kaplan-Meier approach for data with dependent censoring using linear combinations of prognostic covariates.
    Hsu CH; Taylor JM
    Stat Med; 2010 Sep; 29(21):2215-23. PubMed ID: 20812302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estimation of treatment effect under non-proportional hazards and conditionally independent censoring.
    Boyd AP; Kittelson JM; Gillen DL
    Stat Med; 2012 Dec; 31(28):3504-15. PubMed ID: 22763957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Empirical Comparison of the Breslow Estimator and the Kalbfleisch Prentice Estimator for Survival Functions.
    Xia F; Ning J; Huang X
    J Biom Biostat; 2018; 9(2):. PubMed ID: 30370174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimating medical costs from incomplete follow-up data.
    Lin DY; Feuer EJ; Etzioni R; Wax Y
    Biometrics; 1997 Jun; 53(2):419-34. PubMed ID: 9192444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonparametric regression with right-censored covariate via conditional density function.
    Jiang H; Huang L; Xia Y
    Stat Med; 2022 May; 41(11):2025-2051. PubMed ID: 35124839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alternatives to the Kaplan-Meier estimator of progression-free survival.
    Zhang JJ; Sun Z; Yuan H; Wang M
    Int J Biostat; 2020 Sep; 17(1):99-115. PubMed ID: 32892174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. On the role of Volterra integral equations in self-consistent, product-limit, inverse probability of censoring weighted, and redistribution-to-the-right estimators for the survival function.
    Strawderman RL; Baer BR
    Lifetime Data Anal; 2024 Jul; 30(3):649-666. PubMed ID: 38512595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Restricted mean survival time for interval-censored data.
    Zhang C; Wu Y; Yin G
    Stat Med; 2020 Nov; 39(26):3879-3895. PubMed ID: 32767503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival analysis for AdVerse events with VarYing follow-up times (SAVVY)-estimation of adverse event risks.
    Stegherr R; Schmoor C; Beyersmann J; Rufibach K; Jehl V; Brückner A; Eisele L; Künzel T; Kupas K; Langer F; Leverkus F; Loos A; Norenberg C; Voss F; Friede T
    Trials; 2021 Jun; 22(1):420. PubMed ID: 34187527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.